Research Topics

EPAR Technical Report #346
Publication Date: 04/23/2018
Type: Literature Review
Abstract

The private sector is the primary investor in health research and development (R&D) worldwide, with investment annual investment exceeding $150 billion, although only an estimated $5.9 billion is focused on diseases that primarily affect low and middle-income countries (LMICs) (West et al., 2017b). Pharmaceutical companies are the largest source of private spending on global health R&D focused on LMICs, providing $5.6 billion of the $5.9 billion in total private global health R&D per year. This report draws on 10-K forms filed by Pharmaceutical companies with the U.S. Securities and Exchange Commission (SEC) in the year 2016 to examine the evidence for five specific disincentives to private sector investment in drugs, vaccines and therapeutics for global health R&D: scientific uncertainty, weak policy environments, limited revenues and market uncertainty, high fixed costs for research and manufacturing, and imperfect markets. 10-K reports follow a standard format, including a business section and a risk section which include information on financial performance, investment options, lines of research, promising acquisitions and risk factors (scientific, market, and regulatory). As a result, these filings provide a valuable source of information for analyzing how private companies discuss risks and challenges as well as opportunities associated with global health R&D targeting LMICs.

EPAR Research Brief #9
Publication Date: 12/17/2008
Type: Research Brief
Abstract

This quarterly report (Quarter 3, 2008) provides charts of historical and future price information for key commodities including coffee, cotton, cocoa, and cashews. We review historical price data from a variety of sources including the International Coffee Organization, International Cocoa Organization, Cotton Outlook and the Food and Agricultural Organization. This update lists average monthly prices through October 2008 and, for commodities that are sold on a futures market, projected prices through October 2010. The report provides a concise review of selected market bulletins, explaining broad trends for past volatility and future pricing.